Capricor Therapeutics | CAPR - Current Liabilities


Capricor Therapeutics reported $33.64M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Bioline Rx USD 13.67M 1.81M Sep/2025
Capricor Therapeutics USD 33.64M 2.2M Mar/2026
Cipla INR 70.14B 7.16B Mar/2026
Cytokinetics USD 199.18M 3.27M Mar/2026
Geron USD 73.57M 40.25M Mar/2026
Grifols EUR 2.37B 156.97M Dec/2025
Immunic USD 38.36M 7.74M Mar/2026
J&J USD 57.72B 3.59B Mar/2026
Plus Therapeutics USD 7.96M 4.36M Mar/2026
Prothena USD 32.52M 8.33M Mar/2026
PTC Therapeutics USD 923.6M 44.82M Mar/2026
Sarepta Therapeutics USD 499.16M 596.13M Mar/2026